Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.700
0.00 (0.00%)
At close: Mar 19, 2026, 4:00 PM EDT
1.620
-0.080 (-4.71%)
Pre-market: Mar 20, 2026, 9:13 AM EDT
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $172.69 million as of March 20, 2026. Its market cap has increased by 31.67% in one year.
Market Cap
172.69M
Enterprise Value
125.11M
1-Year Change
31.67%
Ranking
Category
Stock Price
$1.70
Market Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $363.46M to $172.69M, a decrease of -52.49%. That is a compound annual growth rate of -10.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 172.69M | -15.84% |
| Dec 31, 2025 | 205.20M | 31.26% |
| Dec 31, 2024 | 156.32M | 117.39% |
| Dec 29, 2023 | 71.91M | -57.49% |
| Dec 30, 2022 | 169.15M | -38.80% |
| Dec 31, 2021 | 276.39M | 38.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protalix BioTherapeutics | 179.34M |
| Acumen Pharmaceuticals | 176.87M |
| Molecular Partners AG | 175.46M |
| Tenaya Therapeutics | 174.40M |
| Cartesian Therapeutics | 174.16M |
| Canton Strategic Holdings | 174.13M |
| Adagene | 173.91M |
| Whitehawk Therapeutics | 169.44M |